In our NAFLD rat model, HQT exerted substantial anti-inflammatory and antioxidant activities, possibly involving the regulation of SIRT1 and Ac-NF-κB-p65 expression. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.